rs1883832: a CD40 single-nucleotide polymorphism for predicting coronary heart disease in humans-Reference-Cited by-同舟云学术

rs1883832: a CD40 single-nucleotide polymorphism for predicting coronary heart disease in humans

Published:2019-11-13 Issue:6 Volume:116 Page:1095-1096
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Lutgens Esther¹²³^ORCID

Affiliation:

1. Department of Medical Biochemistry, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, Amsterdam, The Netherlands

2. Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians University, Munich, Germany

3. German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://academic.oup.com/cardiovascres/advance-article-pdf/doi/10.1093/cvr/cvz286/31081640/cvz286.pdf

Reference15 articles.

1. Atherosclerosis;Libby;Nat Rev Dis Primers,2019

2. Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology;Tuñón;Cardiovasc Res,2019

3. Antiinflammatory therapy with canakinumab for atherosclerotic disease;Ridker;N Engl J Med,2017

4. Low-dose methotrexate for the prevention of atherosclerotic events;Ridker;N Engl J Med,2019

5. Immunotherapy for cardiovascular disease;Lutgens;Eur Heart J,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genetic variant in the CD40 gene is related to HBV infection in the Chinese Han population;Hepatology Communications;2023-12

2. Potential role of soluble CD40 receptor in chronic inflammatory diseases;Biochemical Pharmacology;2023-11

3. Ectodomain Shedding by ADAM17 Increases the Release of Soluble CD40 from Human Endothelial Cells under Pro-Inflammatory Conditions;Cells;2023-07-25

4. The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease;Journal of Cardiovascular Translational Research;2020-03-28